Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma, any site",24610,95,0.30 [0.14-0.66],0.0028343180345822
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Leiomyoma of uterus,13019,364,0.51 [0.34-0.77],0.0012934376367176
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21788,570,1.81 [1.30-2.53],0.0004788974274188
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21818,600,1.89 [1.37-2.62],0.0001223445723529
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,110,0.33 [0.16-0.69],0.0034216812941241
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22937,129,0.48 [0.29-0.78],0.0031766271062547
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24560,233,2.17 [1.31-3.61],0.0027745304454651
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24421,94,3.13 [1.42-6.93],0.0048036475988203
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21076,116,2.71 [1.32-5.57],0.0067061326217328
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21098,138,3.47 [1.79-6.73],0.0002312287103981
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24415,88,3.24 [1.43-7.34],0.005001422312762
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,23035,109,2.78 [1.33-5.82],0.00670266811311
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1509,32,12.91 [3.71-44.98],5.889399378352753e-05
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22900,5418,0.79 [0.71-0.88],1.993336963467793e-05
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertension,23409,4411,0.73 [0.65-0.82],2.3383160727100946e-07
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23418,4420,0.74 [0.66-0.83],4.352538731020214e-07
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19040,42,45.59 [13.88-149.68],3.036249300462019e-10
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24600,106,3.89 [1.81-8.32],0.0004783131092906
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23989,60,3.80 [1.41-10.25],0.0083410348155056
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24503,336,0.39 [0.27-0.55],2.1950205879015058e-07
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24447,393,0.31 [0.21-0.45],3.0253683936200206e-09
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1512,35,15.19 [4.60-50.21],8.17450121653143e-06
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24498,359,0.58 [0.39-0.88],0.009723710572336
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24020,958,0.66 [0.52-0.85],0.0010695115313398
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18225,119,0.36 [0.18-0.75],0.0060967300240422
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19542,1573,0.53 [0.44-0.65],3.5330545487396783e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19648,1542,0.53 [0.44-0.65],7.419167568151487e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23863,2104,0.65 [0.55-0.78],9.994347818393802e-07
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22908,3805,0.79 [0.69-0.90],0.0002627140298033
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute pancreatitis,23203,155,0.36 [0.19-0.67],0.0012272098002715
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute peritonitis,24238,61,4.54 [1.71-12.05],0.0024197933282156
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23953,79,0.47 [0.27-0.81],0.0066313868644153
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of liver,24545,671,0.57 [0.42-0.76],0.0001747021504494
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24627,346,0.51 [0.34-0.77],0.001388511325655
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of liver,24411,537,0.61 [0.44-0.86],0.0040092228715547
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24472,135,0.41 [0.21-0.79],0.0079846771128004
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21625,136,0.40 [0.21-0.79],0.0079881181603373
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24182,763,1.56 [1.18-2.07],0.00181100806807
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23991,572,3.69 [2.67-5.09],2.454447149540692e-15
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24487,20,14.23 [2.71-74.75],0.0017067596002122
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Dialysis,23463,44,2.01 [1.27-3.18],0.0029489519401455
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10314,385,0.56 [0.38-0.83],0.0042473762914112
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24526,59,5.63 [2.09-15.15],0.0006226563229957
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11190,1261,0.70 [0.56-0.87],0.0012421086106405
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24485,1345,1.82 [1.47-2.25],2.8114418540108084e-08
